References
- Balfour JA, Faulds D. (1992). Terbinafine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses. Drugs 43:259–84
- Bangham AD, Standish MM, Watkins JC. (1965). Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13:238–52
- Bhat V, Shivakumar HR, Sheshappa RK, et al. (2012). Influence of blending of chitosan and pullulan on their drug release behavior: an in-vitro study. Int J Pharm Pharm Sci 4:313–17
- Boker A, Burks J. (2007). Can a new nail trephination device help treat nail conditions? Pod Today 20:34–6
- Brazel CS, Peppas NA. (2000). Modeling of drug release from swellable polymers. Eur J Pharm Biopharm 49:47–58
- Brown MB, Khengar RH, Turner RB, et al. (2009). Overcoming the nail barrier: a systematic investigation of ungual chemical penetration enhancement. Int J Pharm 370:61–7
- Chiu C-W, Chang C-H, Yang Y-M. (2013). Gelation of ethosome-like catanionic vesicles by water-soluble polymers: ethanol and cholesterol effects. Soft Matter 9:7628–36
- Clinical and Laboratory Standards Institute. (2008). Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved Standard. CLSI document M38-A2. 2nd ed. Wayne (PA): Clinical and Laboratory Standards Institute
- Darkers MJM, Scott LJ, Goa KL. (2003). Terbinafine: a review of its use in onychomycosis in adults. Am J Clin Dermatol 4:39–65
- Davies KJ. (2006). Study to determine the efficacy of Clotrimazole %1 cream for the treatment of onychomycosis in association with the mechanical reduction of the nail plate. Foot 16:19–22
- Dayan N, Touitou E. (2000). Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials 21:1879–85
- Di Chiacchio N, Kadunc BV, de Almeida ART, Madeira CL. (2004). Nail abrasion. J Cosmet Dermatol 2:150–2
- European Pharmacopoeia. 3rd Edition. Uniformity content of single-dose preparation, 1997, p.134
- Fresta M, Puglisi G. (1996). Application of liposomes as potential cutaneous drug delivery systems: in vitro and in vivo investigation with radioactivity labelled vesicles. J Drug Target 4:95–101
- Fu Y, Kao WJ. (2010). Drug release kinetics and transport mechanisms of nondegradable and degradable polymeric delivery systems. Expert Opin Drug Deliv 7:429–44
- Ghannoum MA, Long L, Kim HG, et al. (2010). Efficacy of terbinafine compared to lanoconazole and luliconazole in the topical treatment of dermatophytosis in a guinea pig model. Med Mycol 48:491–7
- Gunt HB, Kasting GB. (2007). Effect of hydration on the permeation of ketoconazole through human nail plate in vitro. Eur J Pharm Sci 32:254–60
- Gupta AK, Shear NH. (1997). Terbinafine: an update. J Am Acad Dermatol 37:979–88
- Hui X, Lindah Å, Lamel S, Maibach HI. (2013). Onychopharmacokinetics of terbinafine hydrochloride penetration from a novel topical formulation into the human nail in vitro. Drug Dev Ind Pharm 39:1401–7
- Imbert D, Wickett RR. (1995). Topical delivery with liposomes. Cosmet Toiletries 110:32–46
- Kim J-H, Lee CH, Choi H-K. (2001). A method to measure the amount of drug penetrated across the nail plate. Pharm Res 18:1468–71
- Kobayashi Y, Komatsu T, Sumi M, et al. (2004). In vitro permeation of several drugs through the human nail plate: relationship between physicochemical properties and nail permeability of drugs. Eur J Pharm Sci 21:471–7
- Koland M, Sandeep VP, Chayulu NR. (2010). Fast dissolving sublingual films of ondansetron hydrochloride: effect of addivites on in-vivo drug release and mucosal permeation. J Young Pharm 2:216–22
- Marty J-PL. (1995). Amorolfine nail lacquer: a novel formulation. J Eur Acad Dermatol Venereol 4:17–21
- Mezei M, Gulasekharam V. (1982). Liposomes – a selective drug delivery system for the topical route of administration: gel dosage form. J Pharm Pharmacol 34:473–4
- Mididoddi PK, Repka MA. (2007). Characteriztion of holt melt extruded drug delivery systems for onychomycosis. Eur J Pharm Biopharm 66:95–105
- Minghetti P, Casiraghi A, Cilurzo F, Montanari L. (2000). Development of local patches containing melilot extract and ex vivo–in vivo evaluation of skin permeation. Eur J Pharm Sci 10:111–17
- Mohorcic M, Torkar A, Friedrich J, et al. (2007). An investigation into keratinolytic enzymes to enhance ungual drug delivery. Int J Pharm 332:196–201
- Murdan S. (2002). Drug delivery to the nail following topical application. Int J Pharm 236:1–26
- Murdan S. (2008). Enhancing the nail permeability of topically applied drugs. Expert Opin Drug Deliv 5:1267–82
- Nair AB, Vaka SR, Murthy SN. (2011). Transungual delivery of terbinafine by iontophoresis in onychomycotic nail. Drug Dev Ind Pharm 37:1253–8
- Neves J, Amaral MH, Bahia MF. (2008). Performance of an in vitro mucoadhesion testing method for vaginal semisolids: influence of different testing conditions and instrumental parameters. Eur J Pharm Biopharm 69:622–32
- Paavola A, Kilpeläinen I, Yliruusi J, Rosenberg P. (2000). Controlled release injectable liposomal gel of ibuprofen for epidural analgesia. Int J Pharm 199:85–93
- Patel VM, Prajapati BG, Patel MM. (2007). Effect of hydrophilic polymers on buccoadhesive Eudragit patches of propranolol hydrochloride using factorial design. AAPS PharmSciTech 8:119–26
- Pittrof F, Gerhards J, Erni W, Klecak G. (1992). Loceryl® nail lacquer-realisation of a new galenical approach to onychomycosis therapy. Clin Exp Dermatol 17:26–8
- Priya S, Rathnanand M, Nayanabhirama U, et al. (2011). Preparation and evaluation of buccal mucoadhesive patch of betamethasone sodium phosphate for the treatment of oral submucous fibrosis. J Chem Pharm Res 3:56–65
- Repka MA, Mididoddi PK, Stodghill SP. (2004). Influence of human nail eaching for the assessment of topical onychomycosis therapies. Int J Pharm 282:95–106
- Shinde AJ, Garala KC, More HN. (2008). Development and characterization of transdermal therapeutics system of tramadol hydrochloride. Asian J Pharmacol 2:265–9
- Sun W, Zhang N, Li A, et al. (2008). Preparation and evaluation of N3-O-toluyl-fluorouracil-loaded liposomes. Int J Pharm 353:243–50
- Tanrıverdi ST, Özer Ö. (2013). Novel topical formulations of TBF-HCl for treatment of onychomycosis. Eur J Pharm Sci 48:628–36
- Tong Q, Xiao Q, Lim L-T. (2008). Preparation and properties of pullulan-alginate-carboxymethylcellulose blend films. Food Res Int 41:1007–14
- Torkar A, Kristl J, Murdan S. (2007). Low-frequency ultrasound to enhance topical drug delivery to the nail. AAPS J Abstracts AAPS2007-001867
- Vejnovic I, Hounder C, Betz G. (2010). Permeation studies of novel terbinafine formulations containing hydrophobins through human nails in vitro. Int J Pharm 39:767–76
- Walters KA, Flynn GL, Marvel JR. (1983). Physicochemical characterization of the human nail: permeation pattern for water and the homologous alcohols and differences with respect to the stratum corneum. J Pharm Pharmacol 35:28–33
- Wessel S, Gniadecka M, Jemec GBE, Wulf HC. (1999). Hydration of human nails investigated by NIR-FT-Raman spectroscopy. Biochim Biophys Acta 1433:210–16
- Wong CF, Yuen KH, Peh KK. (1999). Formulation and evaluation of controlled release Eudragit buccal patches. Int J Pharm 178:11–22
- Wypych G. (2004). Handbook of plasticizers. Canada: Chem Tec Publishing